CA SB1010

Requires health care service plans and health insurers to report prescription drug cost information (25 most frequently prescribed drugs, 25 most costly drugs, and 25 drugs with highest year-over-year spending increases) to the Department of Managed Health Care and Department of Insurance by October 1 each year, with aggregated reports published publicly.

Mandates prescription drug manufacturers notify state purchasers, health plans, insurers, and pharmacy benefit managers of price increases of 25% or more (or over $10,000) during any 12-month period at least 30 days before the increase takes effect, with reporting requirements to the Office of Statewide Health Planning and Development within 30 days.

Requires manufacturers to notify purchasers three days before commercial availability of new prescription drugs with wholesale acquisition costs of $10,000 or more annually or per course of treatment, with detailed information reported within 30 days.

Imposes $1,000 per day administrative penalties for manufacturers failing to provide required pricing information after the 30-day notification period.

Establishes confidentiality protections for pricing information until the effective date of price increases and repeals these manufacturer notification provisions on January 1, 2022.